Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
-1.45M
-
Total reported value, excl. options
-
$171M
-
Value change
-
-$12.4M
-
Put/Call ratio
-
0.13
-
Number of buys
-
31
-
Number of sells
-
-28
-
Price
-
$7.46
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q3 2023
84 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q3 2023.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 56.3M outstanding shares and own 40.81% of the company stock.
Largest 10 shareholders include FMR LLC (2.57M shares), PERCEPTIVE ADVISORS LLC (2.19M shares), Fairmount Funds Management LLC (1.9M shares), BlackRock Inc. (1.69M shares), Vivo Capital, LLC (1.68M shares), VANGUARD GROUP INC (1.51M shares), Driehaus Capital Management LLC (1.45M shares), Altium Capital Management LP (1.35M shares), Saturn V Capital Management LP (1.22M shares), and Deep Track Capital, LP (1.04M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.